A number of state legislatures are considering bills banning synthetic drugs, requiring education for doctors who prescribe opioids, and expanding the use of the drug overdose antidote naloxone this session, explains Sherry Green, CEO of the National Alliance for Model State Drug Laws.
Category results for "Government"
Food and Drug Administration Commissioner Margaret Hamburg defended the agency’s decision to approve the pure hydrocodone drug Zohydro ER (extended release). At a Senate hearing, Hamburg said, “If appropriately used, it serves an important and unique niche with respect to pain medication and it meets the standards for safety and efficacy.”
Soon after Attorney General Eric Holder began making changes to drug laws, the number of drug defendants charged by the federal government dropped in January to its lowest monthly level in almost 14 years, according to a new report.
U.S. Attorney General Eric Holder is scheduled to testify today in favor of changing federal guidelines to reduce the average sentence for drug dealers, The New York Times reports.
The effectiveness of prescription drug monitoring programs, designed to reduce “doctor shopping” for opioids, has varied greatly by state, according to a new study by Columbia University researchers.
Many people in recovery face an overwhelming array of discriminatory barriers as a result of their addiction and/or criminal histories, which make it difficult to obtain employment, housing, education, public benefits and other necessities of life, says the Legal Action Center.
West Virginia Senator Joe Manchin this week called on Health and Human Services Secretary Kathleen Sebelius to overrule the Food and Drug Administration’s decision to approve the pure hydrocodone drug Zohydro ER (extended release).
Jails and prisons are signing up inmates for health insurance under the Affordable Care Act, according to The New York Times.
U.S. Attorney General Eric Holder on Monday called the increase in heroin overdoses “an urgent and growing public health crisis,” The Washington Post reports.
Substance abuse treatment providers say patients are having problems getting their care covered, even though such treatment is now considered an essential health benefit under the Affordable Care Act.